CJC-1295 WO/Dac + Ipamorelin 10mg Pen

CJC-1295 (No DAC) + Ipamorelin 10mg Pen

This synergistic peptide combination is widely studied in growth hormone signalling and recovery-related research. The “No DAC” version allows for shorter-acting research applications.
Key research focus areas:
* Growth hormone pulsatility
* Recovery and repair pathways
* Lean tissue signalling
* Sleep and recovery models
* Anti-ageing research frameworks
Why this combination works:
* Complementary peptide interaction
* Controlled, predictable signalling
* Clean, non-DAC formulation
* Combined convenience in one pen